Your browser doesn't support javascript.
loading
Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers.
Park, Daniel J; Tao, Kayoko; Le Calvez-Kelm, Florence; Nguyen-Dumont, Tu; Robinot, Nivonirina; Hammet, Fleur; Odefrey, Fabrice; Tsimiklis, Helen; Teo, Zhi L; Thingholm, Louise B; Young, Erin L; Voegele, Catherine; Lonie, Andrew; Pope, Bernard J; Roane, Terrell C; Bell, Russell; Hu, Hao; Huff, Chad D; Ellis, Jonathan; Li, Jun; Makunin, Igor V; John, Esther M; Andrulis, Irene L; Terry, Mary B; Daly, Mary; Buys, Saundra S; Snyder, Carrie; Lynch, Henry T; Devilee, Peter; Giles, Graham G; Hopper, John L; Feng, Bing-Jian; Lesueur, Fabienne; Tavtigian, Sean V; Southey, Melissa C; Goldgar, David E.
Affiliation
  • Park DJ; Genetic Epidemiology Laboratory, Department of Pathology;
  • Tao K; Oncological Sciences and.
  • Le Calvez-Kelm F; Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon;
  • Nguyen-Dumont T; Genetic Epidemiology Laboratory, Department of Pathology;
  • Robinot N; Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon;
  • Hammet F; Genetic Epidemiology Laboratory, Department of Pathology;
  • Odefrey F; Genetic Epidemiology Laboratory, Department of Pathology;
  • Tsimiklis H; Genetic Epidemiology Laboratory, Department of Pathology;
  • Teo ZL; Genetic Epidemiology Laboratory, Department of Pathology;
  • Thingholm LB; Genetic Epidemiology Laboratory, Department of Pathology;
  • Young EL; Oncological Sciences and.
  • Voegele C; Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon;
  • Lonie A; Victorian Life Sciences Computation Initiative;
  • Pope BJ; Department of Computing and Information Systems; Victorian Life Sciences Computation Initiative;
  • Roane TC; University of Texas at Austin, Austin;
  • Bell R; Oncological Sciences and.
  • Hu H; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas;
  • Shankaracharya; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas;
  • Huff CD; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas;
  • Ellis J; The QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; Departments of.
  • Li J; The QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; Departments of.
  • Makunin IV; The QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; Departments of.
  • John EM; Cancer Prevention Institute of California, Fremont; Department of Health Research and Policy, Stanford Cancer Institute, Stanford, California;
  • Andrulis IL; Department of Molecular Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada;
  • Terry MB; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York;
  • Daly M; Fox Chase Cancer Center, Philadelphia, Pennsylvania;
  • Buys SS; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah;
  • Snyder C; Department of Preventive Medicine, Creighton University, Omaha, Nebraska;
  • Lynch HT; Department of Preventive Medicine, Creighton University, Omaha, Nebraska;
  • Devilee P; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands; and.
  • Giles GG; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne; Centre for Cancer Epidemiology, The Cancer Council Victoria, Carlton, Victoria;
  • Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne; School of Public Health, Seoul National University, Seoul, Korea.
  • Feng BJ; Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah;
  • Lesueur F; Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon; Genetic Epidemiology of Cancer Team, Institut National de la Santé et de la Recherche Medicale (INSERM), U900, Institut Curie, Mines ParisTech, Paris, France;
  • Tavtigian SV; Oncological Sciences and.
  • Southey MC; Genetic Epidemiology Laboratory, Department of Pathology; msouthey@unimelb.edu.au david.goldgar@hsc.utah.edu.
  • Goldgar DE; Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah; msouthey@unimelb.edu.au david.goldgar@hsc.utah.edu.
Cancer Discov ; 4(7): 804-15, 2014 Jul.
Article in En | MEDLINE | ID: mdl-25050558
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Colorectal Neoplasms, Hereditary Nonpolyposis / Cell Cycle Proteins Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Cancer Discov Year: 2014 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Colorectal Neoplasms, Hereditary Nonpolyposis / Cell Cycle Proteins Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Cancer Discov Year: 2014 Document type: Article